Effect of pulmonary surfactant on the dispersion of carbon nanoparticles

Abstract

Carbon nanoparticles (CNs) are widely used and there has been a great concern about their potential adverse effects on human health. CNs can directly interact with the pulmonary surfactant (PS) lining of alveoli, but the dispersion state of CNs at PS film has not yet been explored. Accumulating evidences indicated that the degree of dispersion of nanoparticles has a strong influence on their biological activities. This study investigated the effect of PS and its major components on the dispersion state of three representative CNs (fullerene C60, nano carbon powder, graphene oxide). The results demonstrated that suspended concentrations of all three CNs were lower in the presence of PS and its lipid component dipalmitoylphosphatidylcholine (DPPC) than in the presence of bovine serum album (BSA). Compared with PS and DPPC, BSA notably reduced the hydrodynamic diameters of CNs. In addition, the absolute zeta potentials of CNs in the presence of BSA was higher than those in the presence of PS or DPPC, and this result corresponds to the increase of surface oxygen contents of CNs, indicating that relatively high surface oxygen content is beneficial for the dispersion of CNs in alveolus. π-A isotherms demonstrated that the surface tension and phase behavior of PS were obviously altered in the presence of CNs. This study revealed the role of PS and different active components in the dispersion of CNs, which is helpful for deeply understanding CNs alveolar transport and the associated potential hazards to lung health. • Interaction of PS with carbon nanoparticles (CNs) leads to the aggregation of CNs. • Lipids and protein components of PS exert different effects on CNs dispersion. • Hydrodynamic diameter/zeta potential impact the dispersion of CNs with PS component. • Surface oxygen content of CNs governs the dispersion of CNs. • CNs exposure leads to the alternation of phase behavior of PS film.